Home › Funds › M&G Plc › ELV

M&G Plc position in ELV

ELEVANCE HEALTH INC FORMERLY · Health Care

M&G Plc reported holding 295,118 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q2 2026 13F filing — a position valued at US$114.2M, representing 0.59% of its reported portfolio and ranking #49 among its reported holdings. M&G Plc has disclosed ELV holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)295.12K sh
Reported value held$114.21M
Portfolio Weight0.59%
First reportedQ1 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How M&G Plc's ELV position evolved

M&G Plc first disclosed a stake in ELV in Q1 2024 at 391,886 shares (US$203.4M). The position peaked in Q2 2025 at 930,293 shares, worth US$361.9M. Across 10 filings, M&G Plc increased the stake 6 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 295,118 shares valued at US$114.2M. Notable position changes include a 62% increase in Q4 2024 (shares rose 18% over the following quarter), a 38% trim in Q4 2025 (shares fell 16% over the following quarter), a 53% trim in Q1 2026 (shares rose 33% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 391.89K $203.39M New
Q2 2024 405.31K $219.68M Add
Q3 2024 473.09K $246.01M Add
Q4 2024 768.56K $283.60M Add
Q1 2025 796.30K $346.39M Add
Q2 2025 930.29K $361.88M Add
Q3 2025 1.02M $327.88M Add
Q4 2025 628.98K $220.77M Reduce
Q1 2026 295.94K $86.71M Reduce
Q2 2026 295.12K $114.21M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELV and 13F data

ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.25B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELV

All ELV fund holders →

FAQ

How long has M&G Plc held ELV?

M&G Plc has disclosed ELV holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

What is M&G Plc's current position in ELV?

As of Q2 2026, M&G Plc holds 295.12K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $114.21M, representing 0.59% of its reported portfolio and ranking #49.

Has M&G Plc been buying or selling ELV?

In the latest 13F filing (Q2 2026), M&G Plc held unchanged its position in ELV. The position peaked in Q2 2025 at 930.29K shares.

Which other funds hold ELV?

Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.